Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026

robot
Abstract generation in progress

Revvity, Inc. launched new discovery platforms at SLAS2026, including the Opera Phenix OptIQ™ high-content screening system, the EnVision Nexus™ One multimode plate reader, and the AssayMate™ workstation. These innovations aim to accelerate high-throughput drug discovery workflows, spanning sample preparation, screening, advanced imaging, and lab automation. The new technologies are designed to address bottlenecks in phenotypic screening and enhance data quality and automation for various laboratory needs.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)